Progressive supranuclear palsy (PSP), previously believed to be a common cause of
atypical parkinsonism, is now recognised as a range of motor and behavioural syndromes …

The differential diagnosis of parkinsonian syndromes is considered one of the most
challenging in neurology and error rates in the clinical diagnosis can be high even at …

ABSTRACT PSP is a pathologically defined neurodegenerative tauopathy with a variety of
clinical presentations including typical Richardson's syndrome and other variant PSP …

Progressive supranuclear palsy (PSP) is a complex clinicopathologic disease with no
current cure or disease modulating therapies that can only be definitively confirmed at …

Background Clinical differentiation of parkinsonian syndromes is still challenging. Objectives
A fully automated method for quantitative MRI analysis using atlas‐based volumetry …

Introduction Differentiating clinically progressive supranuclear palsy-parkinsonism (PSP-P)
from Parkinson's disease (PD) may be challenging, especially in the absence of vertical …

Tauopathies are both clinical and pathological heterogeneous disorders characterized by
neuronal and/or glial accumulation of misfolded tau protein. It is now well understood that …

It is believed that glycogen synthase kinase‐3 hyperphosphorylates tau protein in
progressive supranuclear palsy (PSP). The Tau Restoration on PSP (TAUROS) trial …

Abstract Background The Magnetic Resonance Parkinsonism Index is listed as one of the
most reliable imaging morphometric markers for diagnosis of progressive supranuclear …

Objectives This study aims at a fully automatic pipeline for measuring the magnetic
resonance parkinsonism index (MRPI) using deep learning methods. Methods MRPI is …